24-Hour NAVA Ventilation in Acute Respiratory Failure
FEASIBILITY OF 24 Hrs VENTILATION WITH NEURALLY ADJUSTED VENTILATORY ASSIST (NAVA) IN PATIENTS WITH ACUTE RESPIRATORY FAILURE
1 other identifier
interventional
15
1 country
1
Brief Summary
Neurally Adjusted Ventilatory Assist (NAVA) is a new mode of mechanical ventilation that is controlled by the electrical activity of the diaphragm (EAdi). The EAdi is a signal that represents the patient's breathing effort, and hence with NAVA, the assist being delivered is synchronized and proportional to the demands of the patient. This is a prospective physiological study of the feasibility of NAVA ventilation over 24 hours. The aim is to demonstrate that NAVA can maintain spontaneous breathing and unload the respiratory muscles during both sleep and wake cycles over a 24 hour period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 20, 2007
CompletedFirst Posted
Study publicly available on registry
December 31, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedJune 1, 2009
May 1, 2009
1.7 years
December 20, 2007
May 29, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of NAVA as assessed by: • Assessment of FiO2 changes • Assessment of the NAVA catheter function: o Stability of the EAdi signal from NAVA catheter o Requirements for NAVA catheter position change • Reasons for ventilator alarms
24 hours
Secondary Outcomes (1)
Patient tolerance of NAVA as assessed by: • Changes in SAS scoring and sedation requirement • Changes in vital signs (HR/BP) and vasopressors requirements • Changes in oxygenation/ventilation
24 hours
Study Arms (1)
NAVA
EXPERIMENTALImplementation of NAVA for 24 hours
Interventions
Mechanical ventilation controlled by diaphragm electrical activity
Eligibility Criteria
You may qualify if:
- Patients admitted to the ICU will be screened on a daily basis for the presence of the following characteristics:
- Adult (\>18 years old) intubated and mechanically ventilated patients with evidence of spontaneous breathing defined as:
- Patient is on pressure support ventilation OR
- Patient is on pressure control ventilation with the ability to trigger 50% of the breaths.
- Sedation Agitation Score (SAS) score greater than or equal to 2
- Presence of an arterial line
- Patients meeting these criteria will be considered eligible for recruitment into the study
You may not qualify if:
- Next of kin unavailable
- Patient/next of kin refuses informed consent.
- Attending physician refuses to allow enrollment
- Pregnancy
- Any contraindication to insertion of a nasogastric tube including, but not limited to: severe oropharyngeal malformation or bleeding, esophageal varices, tumor, infection, stenosis, or rupture
- Hemophilia or other severe bleeding disorder
- Presence or suspicion of central/brain stem neurologic disorder/severe neuromuscular disease
- Treatment with neuromuscular blockers
- History of heart and/or lung transplantation
- Mean arterial blood pressure \< 60 mm Hg with or without vasopressors or inotropes
- Any contraindication to reducing sedation to obtain a targeted SAS score of 3 (e.g. anticipated hemodynamic instability after reduction of sedation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St-Michael's Hospital
Toronto, Ontario, M5B1W8, Canada
Related Publications (5)
Sinderby C, Navalesi P, Beck J, Skrobik Y, Comtois N, Friberg S, Gottfried SB, Lindstrom L. Neural control of mechanical ventilation in respiratory failure. Nat Med. 1999 Dec;5(12):1433-6. doi: 10.1038/71012. No abstract available.
PMID: 10581089BACKGROUNDSinderby C. Ventilatory assist driven by patient demand. Am J Respir Crit Care Med. 2003 Oct 1;168(7):729-30. doi: 10.1164/rccm.2307004. No abstract available.
PMID: 14522808BACKGROUNDBeck J, Brander L, Slutsky AS, Reilly MC, Dunn MS, Sinderby C. Non-invasive neurally adjusted ventilatory assist in rabbits with acute lung injury. Intensive Care Med. 2008 Feb;34(2):316-23. doi: 10.1007/s00134-007-0882-x. Epub 2007 Oct 25.
PMID: 17960364BACKGROUNDBeck J, Campoccia F, Allo JC, Brander L, Brunet F, Slutsky AS, Sinderby C. Improved synchrony and respiratory unloading by neurally adjusted ventilatory assist (NAVA) in lung-injured rabbits. Pediatr Res. 2007 Mar;61(3):289-94. doi: 10.1203/01.pdr.0000257324.22406.93.
PMID: 17314685BACKGROUNDAllo JC, Beck JC, Brander L, Brunet F, Slutsky AS, Sinderby CA. Influence of neurally adjusted ventilatory assist and positive end-expiratory pressure on breathing pattern in rabbits with acute lung injury. Crit Care Med. 2006 Dec;34(12):2997-3004. doi: 10.1097/01.CCM.0000242520.50665.9F.
PMID: 16957635BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fabrice Brunet, MD
Unity Health Toronto
- PRINCIPAL INVESTIGATOR
Christer Sinderby, PhD
Unity Health Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 20, 2007
First Posted
December 31, 2007
Study Start
May 1, 2006
Primary Completion
January 1, 2008
Study Completion
May 1, 2008
Last Updated
June 1, 2009
Record last verified: 2009-05